Stock futures edged higher despite the trade war between the world's largest economies spiraled further Friday, with China lifting tariffs on the U.S . to 125% and scoffing that further U.S. levies ...

The new hospital, officially named the Novo CHUAC (New University Hospital of A Coruña), is one of the most ambitious public ...

The Strategy trailed its core benchmark but bested its growth index, supported by strength among communication services and ...

While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire ...

Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

Helge Lund, its Chairman, will be stepping down after a “fundamental” strategy reset to cut renewable investments & grow ...

If these findings are confirmed in humans, it could have implications for treating many diseases where the immune system ...

Novo Nordisk revealed a stunning increase in pollution amid plans to boost production of its popular weight loss drug Wegovy.

Artisan Partners, an investment management company, released its “Artisan Global Opportunities Fund” fourth quarter 2024 ...

Danish drugmaker Novo Nordisk has been dethroned by German software giant SAP as Europe’s most valuable company. SAP has soared some 40 per cent over the last year as investors celebrated its ...

Novo Nordisk (NVO) announced on Saturday that a late-stage trial for its popular weight loss therapy Ozempic in adults with type 2 diabetes and a vascular disorder known as peripheral artery ...

Novo Nordisk shares are experiencing a significant decline amidst intensified investor concerns over its competitiveness in the obesity drug market against U.S. rival Eli Lilly. The company's stock ...